Clover Corporation Limited (CLV) AI Stock Analysis

• Market Cap: AU$132.76M
• Dividend Yield: 2.19%
• Average Volume (3M): 223.73K
• Price to Earnings (P/E): 18.9
• Beta (1Y): -0.32
• Revenue Growth: 38.25%
• EPS Growth: 361.54%
• Country: AU
• Employees: 60
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.03
• Shares Outstanding: 166,999,340
• 10 Day Avg. Volume: 49,116
• 30 Day Avg. Volume: 223,729
• PEG Ratio: 0.04
• Price to Book (P/B): 1.28
• Price to Sales (P/S): 1.08
• P/FCF Ratio: 13.34
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: AU$1.00 ▲(25.00% Upside)

Clover Corporation Limited has a strong financial foundation with robust revenue growth and profitability. The technical indicators suggest bullish momentum, though caution is advised due to overbought signals. The valuation is fair, providing a balanced risk-reward profile.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.

Balance Sheet Health

A low debt-to-equity ratio reflects minimal leverage, reducing financial risk and enhancing the company's ability to invest in growth opportunities.

Profitability Margins

Strong profitability margins suggest effective cost management and operational efficiency, contributing to sustained financial health and competitive advantage.

Negative Factors

Decline in Free Cash Flow Growth

A significant decline in free cash flow growth can limit the company's ability to reinvest in the business, potentially impacting future growth and financial flexibility.

Limited Earnings Call Data

Lack of earnings call data may hinder transparency and investor confidence, affecting the company's ability to communicate strategic initiatives and financial performance.

Lack of Corporate Events

Absence of corporate events could indicate a lack of strategic initiatives or partnerships, potentially impacting the company's growth prospects and market positioning.

Clover Corporation Limited Business Overview & Revenue Model

Company Description

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy living–brain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.

How the Company Makes Money

Clover Corporation generates revenue through the sale of its food ingredient products, particularly natural colorants and flavor enhancers. The company’s revenue model is based on direct sales to food manufacturers and distributors, which allows it to reach a broad customer base across various segments including confectionery, dairy, and beverages. Key revenue streams include bulk sales of colorants, customized formulations for specific customer needs, and ongoing research and development collaborations with industry partners. Additionally, Clover may benefit from strategic partnerships with larger food companies that seek to enhance their product offerings with natural ingredients, further contributing to its earnings.

Clover Corporation Limited Financial Statement Overview

Summary

Clover Corporation Limited shows strong financial health with impressive revenue growth and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth could pose a risk if not addressed.

Income Statement

Clover Corporation Limited has demonstrated strong revenue growth of 18.64% in the latest year, with improving gross profit and net profit margins at 30.43% and 8.16%, respectively. The EBIT and EBITDA margins also show a healthy profitability trend at 12.42% and 14.23%. This indicates a robust financial performance with effective cost management and operational efficiency.

Balance Sheet

The company's balance sheet is solid with a low debt-to-equity ratio of 0.03, indicating minimal leverage and financial risk. The return on equity is 9.71%, reflecting decent profitability relative to shareholder equity. The equity ratio stands at 83.23%, showcasing a strong capital structure with significant equity backing.

Cash Flow

While the operating cash flow to net income ratio is healthy at 0.65, indicating good cash generation relative to earnings, the free cash flow growth has declined by 62.47%. The free cash flow to net income ratio of 0.84 suggests that the company is generating sufficient cash to cover its net income, but the decline in free cash flow growth is a concern.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	86.00M	86.00M	62.21M	79.88M	70.66M	60.51M
Gross Profit	26.17M	26.17M	16.86M	23.74M	21.66M	18.24M
EBITDA	11.78M	12.24M	3.98M	10.01M	11.66M	10.23M
Net Income	7.01M	7.01M	1.51M	6.21M	7.13M	6.00M
Balance Sheet
Total Assets	86.80M	86.80M	84.39M	86.20M	90.77M	78.73M
Cash, Cash Equivalents and Short-Term Investments	8.68M	8.68M	12.26M	9.44M	10.11M	9.09M
Total Debt	2.42M	2.42M	10.39M	11.71M	12.08M	14.19M
Total Liabilities	14.57M	14.57M	17.32M	19.05M	27.73M	20.32M
Stockholders Equity	72.23M	72.23M	67.07M	67.15M	63.04M	58.42M
Cash Flow
Free Cash Flow	6.95M	6.95M	6.13M	5.10M	4.51M	6.40M
Operating Cash Flow	8.29M	8.29M	8.45M	6.74M	5.93M	8.23M
Investing Cash Flow	-1.34M	-1.34M	-2.97M	-2.53M	-1.43M	-1.83M
Financing Cash Flow	-10.52M	-10.52M	-2.66M	-4.88M	-3.49M	-6.55M

Clover Corporation Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.8 is above the 20-day moving average (MA) of 0.79, above the 50-day MA of 0.76, and above the 200-day MA of 0.59, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.14 is Neutral, neither overbought nor oversold. The STOCH value of 44.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.

Clover Corporation Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLV	74 Outperform	AU$132.76M	18.93	10.07%	2.19%	38.25%	361.54%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BUB	60 Neutral	AU$120.71M	22.58	13.97%	―	28.66%	―
HCT	43 Neutral	AU$30.53M	36.09	―	―	6.76%	―
NGS	43 Neutral	AU$7.33M	-0.67	―	―	-21.84%	79.99%
AHF	40 Underperform	AU$21.56M	-4.17	-20.54%	―	13.92%	36.28%
NUC	38 Underperform	AU$21.00M	-5.17	-29.43%	―	102.21%	69.47%

Clover Corporation Limited Corporate Events

Clover Corporation Announces Director’s Change in Securities Holdings

Clover Corporation Limited announced a change in the director’s interest, specifically involving Peter Davey. The change reflects an increase in the number of performance rights held directly by the director, with 529,638 performance rights acquired and 255,199 disposed of, resulting in a total of 1,361,706 performance rights held. This adjustment in holdings may indicate strategic positioning or confidence in the company’s future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation’s AGM Approves Key Resolutions for Strategic Growth

Clover Corporation Limited held its Annual General Meeting on November 18, 2025, where several key resolutions were passed. The shareholders approved the adoption of the remuneration report, re-elected Dr. Simon Green and elected Ms. Fiona Pearse as directors, approved the acquisition of performance rights for the Managing Director, endorsed the long-term incentive plan, and adopted a new constitution. These decisions reflect the company’s strategic focus on governance and incentive alignment, potentially impacting its operational efficiency and stakeholder engagement positively.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Reports Strong FY25 Performance and Strategic Growth Initiatives

Clover Corporation Limited reported a strong financial year in FY25, marked by a significant increase in sales and improved financial performance due to a successful diversification strategy. The company achieved notable milestones, including the commissioning of a fish oil extraction facility in Ecuador and the first full year of profit at Melody Dairies. The company is poised for further growth through its new distributor model and the promising CholineXcel project, targeting infant and prenatal nutrition markets, while continuing to explore opportunities in high-value nutraceutical markets.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Announces Change in KMP Shareholding

Clover Corporation Limited announced a change in the interest of its Key Management Personnel, Andrew Allibon, who has acquired an additional 2,447 ordinary shares through an on-market purchase. This change reflects a slight increase in insider ownership, which may indicate confidence in the company’s future prospects and could positively influence stakeholder perception.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Director Increases Shareholding

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring 62,996 ordinary shares through an on-market purchase, increasing her total holdings to 149,028 shares. This transaction, valued at $40,050, reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which could positively impact stakeholder perceptions.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Director Increases Shareholding

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 31,000 ordinary shares through an on-market purchase, increasing her total holdings to 86,032 shares. This acquisition reflects a strategic move by the director, potentially signaling confidence in the company’s future performance and stability, which could have positive implications for stakeholders and market perception.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Announces 2025 AGM and Annual Report Release

Clover Corporation Limited has announced the details of its 2025 Annual General Meeting (AGM), scheduled for November 18, 2025, to be held in a hybrid format allowing both in-person and online participation. The AGM will provide shareholders an opportunity to engage with the company’s board, discuss the company’s performance, and vote on key resolutions. The company has also released its 2025 Annual Report, which is available on its website. The board recommends shareholders vote in favor of resolutions 2 to 6, while abstaining from a recommendation on resolution 1 due to its nature concerning the remuneration report.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Director Increases Shareholding

Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 14,492 ordinary shares through an on-market purchase, increasing her total holdings to 55,032 shares. This acquisition reflects a continued commitment to the company and may indicate confidence in its future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.